Increased concentration of cerebral kynurenic acid alters stimulus processing and conditioned responding

Behavioural Brain Research

Volumn 170, Issue 2, 2006, Pages 326-332

  Chess, Amy C ^a   Bucci, David J ^a  

^a DARTMOUTH COLLEGE   (United States)

Author keywords

Acetylcholine; Attention; Kynurenic acid; Nicotinic; Orienting; Pre exposure; Schizophrenia

Indexed keywords

KYNURENIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENTION; BRAIN DEPTH STIMULATION; COGNITIVE DEFECT; CONDITIONING; ENVIRONMENT; MALE; NONHUMAN; ORIENTATION; PRIORITY JOURNAL; RAT; REWARD; STANDING; VISUAL STIMULATION;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; EXCITATORY AMINO ACID ANTAGONISTS; FEEDING BEHAVIOR; KYNURENIC ACID; MALE; MOTOR ACTIVITY; ORIENTATION; PHOTIC STIMULATION; RATS; RATS, LONG-EVANS;

EID: 33747459300     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2006.03.006     Document Type: Article

References (39)

1. Adler L.E., Pachtman E., Franks R.D., Pecevich M., Waldo M.C., and Freedman R. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry 17 (1982) 639-654
2. Baran H., Jellinger K., and Deecke L. Kynurenine metabolism in Alzheimer's disease. J Neural Transm 106 (1999) 165-181
3. Baxter M.G., Bucci D.J., Holland P.C., and Gallagher M. Impairments in conditioned stimulus processing and conditioned responding after combined selective removal of hippocampal and neocortical cholinergic input. Behav Neurosci 113 (1999) 486-495
4. Baxter M., Holland P.C., and Gallagher M. Disruption of decrements in conditioned stimulus processing by selective removal of hippocampal cholinergic input. J Neurosci 17 (1997) 5230-5236
5. Braff D.L., Geyer M.A., and Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156 (2001) 234-258
6. Bucci D.J., Holland P.C., and Gallagher M. Removal of cholinergic input to rat posterior parietal cortex disrupts incremental processing of conditioned stimuli. J Neurosci 18 (1998) 8038-8046
7. Chiba A.A., Bucci D.J., Holland P.C., and Gallagher M. Basal forebrain cholinergic lesions disrupt increments but not decrements in conditioned stimulus processing. J Neurosci 15 (1995) 7315-7322
8. Erhardt S., Schwieler L., Emanuelsson C., and Geyer M. Endogenous kynurenic acid disrupts prepulse inhibition. Biol Psychiatry 56 (2004) 255-260
9. Gallagher M., Graham P.W., and Holland P.C. The amygdala central nucleus and appetitive pavlovian conditioning: lesions impair one class of conditioned behaviour. J Neurosci 10 (1990) 1906-1911
10. Graham A.J., Ray M.A., Perry E.K., Jaros E., Perry R.H., Volsen S.G., et al. Differential nicotinic acetylcholine receptor subunit expression in the human hippocampus. J Chem Neuroanat 25 (2003) 97-113
11. Grau J.W., and Rescorla R.A. The role of context in autoshaping. J Exp Psychol Anim Behav Process 10 (1984) 324-332
12. Han J.-S., Gallagher M., and Holland P. Hippocampal lesions disrupt decrements but not increments in conditioned stimulus processing. J Neurosci 15 (1995) 7323-7329
13. Hilmas C., Pereira E.F.R., Alkondon M., Rassoulpour A., Schwarcz R., and Albuquerque E.X. The brain metabolite kynurenic acid inhibits α7 nicotinic receptor activity and increases non-α7 nicotinic receptor expression: physiopathological implications. J Neurosci 21 (2001) 7463-7473
14. Holland P.C. Conditioned stimulus as a determinant of the form of the Pavlovian conditioned response. J Exp Psychol Anim Behav Process 3 (1977) 77-104
15. Holland P.C., Lamoureux J.A., Han J.-S., and Gallagher M. Hippocampal lesions interfere with pavlovian negative occasion setting. Hippocampus 9 (1999) 143-157
16. Kaye H., and Pearce J.M. The strength of the orienting response during Pavlovian conditioning. J Exp Psychol Anim Behav Process 10 (1984) 90-109
17. Kaye H., and Pearce J.M. Hippocampal lesions attenuate latent inhibition and the decline of the orienting response in rats. Q J Exp Psychol 39B (1987) 107-125
18. Kumari V., and Postma P. Nicotine use in schizophrenia: the self medication hypotheses. Neurosci Biobehav Rev 29 (2005) 1021-1034
19. Lopes C., Pereira E.F.R., Wu H., Rassoulpour A., Schwarcz R., and Albuquerque E.X. In vitro and in vivo interactions between kynurenic acid and the nicotinic allosteric potentiating ligand galantamine: clinical relevance (2005), Society for Neuroscience, Washington, DC (Program No. 953.12. 2005 Abstract Viewer/Itinerary Planner)
20. Lubow R.E. Construct validity of the animal latent inhibition model of selective attention deficits in schizophrenia. Schizophr Bull 31 (2005) 139-153
21. Martins Serra A., Jones S.H., Toone B., and Gray J.A. Impaired associative learning in chronic schizophrenics and their first-degree relatives: a study of latent inhibition and the Kamin blocking effect. Schizophr Res 48 (2001) 273-289
22. Matsuoka N., and Aigner T.G. The glycine/NMDA receptor antagonist HA-966 impairs visual recognition memory in rhesus monkeys. Brain Res 731 (1996) 72-78
23. Ohno M., Yamamoto T., and Watanabe S. Intrahippocampal administration of a glycine site antagonist impairs working memory performance of rats. Eur J Pharmacol 253 (1994) 183-187
24. Parsons C.G., Danysz W., Quack G., Hartmann S., Lorenz B., Wollenburg C., et al. Novel systemically active antagonists of the glycine site of the N-methyl-d-aspartate receptor: electrophysiological, biochemical and behavioural characterization. J Pharmacol Exp Ther 283 (1997) 1264-1275
25. Pearce J.M., and Hall G. A model for pavlovian learning: variations in the effectiveness of conditioned but not of unconditioned stimuli. Psychol Rev 106 (1980) 532-552
26. Pereira E.F.R., Hilmas C., Santos M.D., Alkondon M., Maelicke A., and Albuquerque E.X. Unconventional ligands and modulators of nicotinic receptors. J Neurobiol 53 (2002) 479-500
27. Rassoulpour A., Wu H.Q., Albuquerque E.X., and Schwarcz R. Prolonged nicotine administration results in biphasic, brain-specific changes in kynurenate levels in the rat. Neuropsychopharmacology 30 (2005) 697-704
28. Sacco K.A., Bannon K.L., and George T.P. Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. J Psychopharmacol 18 (2004) 457-474
29. Schwarcz R., and Pellicciari R. Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther 303 (2002) 1-10
30. Schwarcz R., Rassoulpour A., Wu H.-Q., Medoff D., Tamminga C.A., and Roberts R.C. Increased cortical kynurenate content in schizophrenia. Biol Psychiatry 50 (2001) 521-530
31. Seifert G., Schilling K., and Steinhauser C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat Rev Neurosci 7 (2006) 194-205
32. Shepard P.D., Joy B., Clerkin L., and Schwarcz R. Micromolar brain levels of kynurenic acid are associated with a disruption of auditory sensory gating in the rat. Neuropsychopharmacology 28 (2003) 1454-1462
33. Stone T.W. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 45 (1993) 309-379
34. Swan J.A., and Pearce J.M. The orienting response as an index of stimulus associability in rats. J Exp Psychol Anim Behav Process 14 (1988) 292-301
35. Tribollet E., Bertrand D., Marguerat A., and Raggenbass M. Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain. Neuroscience 12 (2004) 405-420
36. Vaitl D., Lipp O., Bauer U., Schuler G., Stark R., Zimmermann M., et al. Latent inhibition and schizophrenia: pavlovian conditioning of autonomic responses. Schizophr Res 55 (2002) 147-158
37. Vécsei L., and Beal M.F. Intracerebroventricular injection of kynurenic acid, but not kynurenine, induces ataxia and stereotyped behaviour in rats. Brain Res Bull 25 (1990) 623-627
38. Volterra A., and Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 6 (2005) 626-640
39. Wilson P., Boumphrey P., and Pearce J.M. Restoration of the orienting response to a light by a change in its predictive accuracy. Q J Exp Psychol 44B (1992) 17-36